StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
ADTX

Aditxt, Inc.

ADTX OTC Pharmaceutical Preparations EDGAR ↗
$0.00
+0.00 0.00%

Key statistics

from XBRL data in SEC filings
Market cap
$2.45K
Revenue (TTM)
$14.3K
Net income (TTM)
-$53.3M
EPS (TTM)
$196,128.66
P/E ratio
0.0
Dividend yield
Free cash flow
-$25.7M
Cash
$269K
Total assets
$13.9M
Gross margin
19.9%
52-week range
$0.00 – $31,364.28

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Entered a material agreement; Unregistered sale of equity Jul 17, 2026 8-K Delisting notice or listing-rule failure Jun 24, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Jun 23, 2026 8-K Entered a material agreement; Regulation FD disclosure Jun 10, 2026 8-K Entered a material agreement; Unregistered sale of equity Jun 9, 2026 8-K Director or officer change Jun 5, 2026 8-K Director or officer change; Regulation FD disclosure Jun 1, 2026 8-K Delisting notice or listing-rule failure May 29, 2026 10-Q Quarter ended 2026-03-31 May 20, 2026 8-K Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure May 15, 2026 8-K Delisting notice or listing-rule failure May 8, 2026 8-K Shareholder vote results May 1, 2026 8-K Entered a material agreement; Took on a direct financial obligation Apr 14, 2026 8-K/A AMENDMENT NO. 1 TO FORM 8-K Apr 7, 2026 8-K Other events Apr 2, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 8-K Other events Mar 30, 2026 8-K Entered a material agreement; Completed an acquisition or disposition; Took on a direct financial obligation; Unregistered sale of equity; Amended charter or bylaws; Other events Mar 13, 2026 8-K Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure Mar 5, 2026 8-K Shareholder vote results Feb 13, 2026 8-K Other events Jan 30, 2026 8-K Other events Jan 28, 2026 8-K Delisting notice or listing-rule failure Dec 5, 2025 8-K Other events Nov 18, 2025 10-Q Quarter ended 2025-09-30 Nov 18, 2025 8-K Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure Oct 31, 2025 8-K Terminated a material agreement Oct 20, 2025 8-K Entered a material agreement Oct 3, 2025 8-K Shareholder vote results Sep 24, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Other events Sep 16, 2025 8-K Entered a material agreement Aug 27, 2025 8-K/A AMENDMENT NO. 6 TO FORM 8-K Aug 18, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Regulation FD disclosure Aug 11, 2025 8-K Director or officer change; Item 5.08 Aug 8, 2025 8-K Regulation FD disclosure Jul 24, 2025 8-K Regulation FD disclosure Jul 21, 2025 8-K Regulation FD disclosure Jul 10, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure Jul 1, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Other events Jun 25, 2025